REGISTERED
on 18 Apr 2023
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
88697701 filed on 19th Nov 2019
Registration Number
7031370 registered on 18th Apr 2023
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
AMJEVITA
pharmaceutical preparations and biosimilars for the treatment of autoimmune diseases and disorders; pharmaceutical preparations and biosimilars for the treatment of rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical preparations and biosimilars for the treatment of autoimmune diseases and disorders; pharmaceutical preparations and biosimilars for the treatment of rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis
First Use Date in General
31st Jan 2023
First Use Date in Commerce
31st Jan 2023
Specimens
Mark Details
Serial Number
No 88697701
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TM-1399-US-3
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Apr 2023 | REGISTERED-PRINCIPAL REGISTER |
| 18th Apr 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 17th Mar 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 16th Mar 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 25th Feb 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 23rd Feb 2023 | TEAS STATEMENT OF USE RECEIVED |
| 23rd Feb 2023 | USE AMENDMENT FILED |
| 09th Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Sep 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 08th Sep 2022 | SOU EXTENSION 5 GRANTED |